First GLP-1 pills for weight loss go on sale in Australia
Resumen detallado
Australians can access the first GLP-1 pills for weight loss through private prescription from Friday, likely boosting sales of the popular drugs already used by more than half a…
Australians can access the first GLP-1 pills for weight loss through private prescription from Friday, likely boosting sales of the popular drugs already used by more than half a million people here.
Glucagon-like peptide-1 receptor agonists, or GLP-1s, were previously only available through a weekly injection, while the new Wegovy and Foundayo pills are taken as daily oral tablets.
Millions of Australians are expected to use GLP-1s in the coming years, with the drugs boasting powerful health effects including significant weight loss, improved blood glucose control and other metabolic health benefits.
However, experts have warned there is a lack of research into the wider effects of the medications, including the risk of malnutrition, which can cause serious health concerns but go unnoticed as symptoms of nutrient deficiency mimic the side effects of GLP-1s, including fatigue, nausea, diarrhoea and constipation.
The medications work by curbing appetite, slowing digestion and promoting feelings of fullness.
The Wegovy pill, manufactured by Novo Nordisk, was approved by the TGA earlier this month.
It’s taken every morning on an empty stomach and stays stable at room temperature, unlike the injectable Wegovy, which requires refrigeration.
The new tablet’s pricing will vary by dose, ranging from about $260 per month for a 1.5mg tablet to $395 a month for 25mg. For patients on the lower doses, this works out at less than $10 a day.
The pill is cheaper than the injectable, which costs between $350 and $500 per month.
Inicio del artículo, extracto de The Sydney Morning Herald. Para leer el resto, abra el artículo en el sitio del medio.
MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.smh.com.au)



